SAN DIEGO--(BUSINESS WIRE)--
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and
manufacturer of the t:slim®, t:slim G4™ and t:flex® Insulin Pumps, today
announced that Henry Anhalt, DO, FACOP, FACE has stepped down from its
board of directors. Dr. Anhalt is chief medical officer of T1D Exchange,
a program of the nonprofit organization Unitio, that fosters
collaboration among patients, physicians, researchers and industry to
speed discovery of better therapies for type 1 diabetes. Prior to his
appointment in March 2016, Dr. Anhalt had the support of T1D Exchange to
serve on Tandem's Board. The non-profit's governing body had conducted a
thorough review of any risk of potential for conflict of interest.
Following the announcement of Dr. Anhalt's appointment to Tandem's
Board, T1D Exchange received member concerns about potential conflicts
of interest, and as a result, Dr. Anhalt has notified Tandem that he
regrettably is no longer able to serve on its board of directors.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com)
is a medical device company with an innovative, user-centric and
integrated approach to the design, development and commercialization of
products for people with diabetes who use insulin. The Company
manufactures and sells the t:slim® Insulin Pump, the slimmest and
smallest durable insulin pump currently on the market, the t:flex®
Insulin Pump, the first pump designed for people with greater insulin
requirements, and the t:slim G4™ Insulin Pump, the first CGM-enabled
pump with touch-screen simplicity. Tandem is based in San Diego,
California.
Follow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslim,
#tslimG4, #tflex, #tconnect, and $TNDM.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/TandemDiabetes.
t:slim, t:flex and Tandem Diabetes Care are registered trademarks, and
t:slim G4 is a trademark of Tandem Diabetes Care, Inc.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160408005954/en/
Tandem Diabetes Care, Inc.
Media Contact:
Steve Sabicer
714-907-6264
ssabicer@thesabicergroup.com
or
Investor
Contact:
Susan Morrison
858-366-6900 x7005
smorrison@tandemdiabetes.com
Source: Tandem Diabetes Care, Inc.
News Provided by Acquire Media
